Sacituzumab govitecan: a promising antibody-drug conjugate for the treatment of poorly differentiated endometrial cancer. Academic Article

Overview

authors

Webster, Emily
Zeybek, Burak
Tymon-Rosario, Joan
Santin, Alessandro D

publication date

June 8, 2020

published in

Oncoscience Journal

Identity

PubMed Central ID

PMC7640901

Digital Object Identifier (DOI)

10.18632/oncoscience.514

PubMed ID

33195736

Additional Document Info

volume

7

issue

9-10